Thrixen

We are partnering with Thrixen to develop a multiplex, rapid, point-of-care (PoC) diagnostic capable of distinguishing between orthoebolaviruses (Zaire and Sudan) and malaria. Under this contract, BARDA will fund the development of the diagnostic to detect orthoebolaviruses, while Thrixen will fund the development of the diagnostic to detect malaria. The Multiplex PoC Diagnostics Platform is designed to use fingerstick blood samples without the need for complex samples processing. The system will be portable and battery-operated, making it suitable for use in remote environments with limited resources. A common issue during Ebola outbreaks is that other endemic diseases, such as malaria, present similar symptoms in the early stages. Rapid identification and differential diagnosis at PoC settings can help healthcare providers make more informed decisions about patient management, initiate treatment earlier, improve patient outcomes, and help prevent the spread of disease. Learn more about this award: https://ow.ly/xTHs50Ul9gr

Singapore has seen significant growth in recent years in the number of start-ups and investments in the healthtech sector, driving technology advancements and expanding new avenues for innovative health solutions. Last week, we partnered with NUS Medicine Digital Advanced Technology Accelerator to host an engaging discussion with Shavit N. Clein, CEO of Thrixen and Paul Scibetta, Co-Founder of 22Health Ventures. Together, we explored Thrixen's journey to becoming a global healthtech leader with deep insights from 22Health Ventures. The session was truly inspiring as Shavit and Paul highlighted the importance of collaboration and community in driving technology innovation. Fostering a culture of support, participating in meaningful interactions, and building strong partnerships will be crucial for organisations in navigating future challenges and delivering impactful innovations. A special thanks to NUS Medicine Digital Advanced Technology Accelerator for the collaboration and all guests who came by for a wonderful evening. We look forward to seeing you next time! #healthtech #health #startup #innovation

🎉 Last week, we had the third and final instalment of our "Meet the Start-Ups" networking series for the academic year! Held in collaboration with the Office of Innovation and Entrepreneurship of Duke-NUS Medical School and moderated by Jessie Wong Ling Ai, the event featured Debleena Ray. PhD from 2Strands Biosciences and Patthara Kongsuphol from Thrixen, who shared their incredible journeys from academia to industry. 🌟 Debleena and Patthara highlighting the importance of seizing opportunities and exploring different paths. They discussed the value of PhD training in developing versatile skills and the differences between scientific freedom in academia and the structured paths in the industry. 🤝 Networking was a key focus, with both speakers stressing the value of connecting with like-minded individuals in the community. The session ended on a fun note with impromptu pitches from Debleena and Patthara to the audience, followed by a vibrant networking session over dinner! A big thank you to the Office of Innovation and Entrepreneurship of Duke-NUS Medical School for partnering with us and all those who came down for the event! Stay tuned for more exciting events by connecting with us here: https://lnkd.in/gq9p76nM #HealthTech #Networking #CareerDevelopment #StartUps #DukeNUS #Innovation #Biotech Kim Whye Leong Liyana Ayub Ow Yong Jiang Yeow Ying Tong Yeo Shruti Sridhar Damien Chua Gloria Chan Isha Karnik Ivan Seah, MBBS/MBA/MPH John Joson Ng Jessie Wong Ling Ai Jiaqi Liang Samantha Wong Hana Maldivita Tambrin Jashan Singh Diya Srivastava Dillon Chew Dijin Zhang Panida Cen Senuri De Silva

🔥One week to Meet the Start-Ups: Finding Your Career Path in Health Technology Our Meet the Start-Ups series returns next week, focusing on the vibrant health technology sector!🩺💻 Jointly organised by Duke-NUS Medical School and the Office of Innovation & Entrepreneurship (OIE), this session features Debleena Ray. PhD, Founder of 2StrandsBiosciences, and Patthara Kongsuphol. PhD, CTO of Thrixen. Don’t miss this chance to learn about the latest opportunities and challenges in the field, connect with industry leaders, and network with like-minded peers over delicious food and drinks! 🥂 📅 Date: July 9, 2024 🕧 Time: 6:00 PM - 7:30 PM 📍 Location: Amphitheatre, Level 2, Duke-NUS Medical School, 8 College Rd, Singapore 169857 🔗RSVP: https://lnkd.in/gn_KjHsh or scan the QR code See you there! #HealthTech #StartUps #CareerDevelopment #Networking #Innovation #Entrepreneurship #DukeNUS Samantha Wong Jiaqi Liang Ivan Seah, MBBS/MBA/MPH Ying Tong Yeo Shruti Sridhar Damien Chua Jessie Wong Ling Ai John Joson Ng Liyana Ayub Ow Yong Jiang Yeow Kim Whye Leong Ignacius Tay Gloria Chan Isha Karnik

Big boost for health diagnostics: #Deeptech #spinoff Thrixen has recently raised US$7 million in a funding round co-led by 22Health Ventures and John Ballantyne, co-founder of #biotech firm Aldevron. Thrixen plans to use the funds to advance its #diagnostic tech platform, which enables multiplex diagnostic tests at the point of care. Their proprietary #assay #technology, which replaces antibodies with a protein engineering platform, has demonstrated 99.5 per cent sensitivity in earlier clinical trials for immunity against the COVID-19 virus. Currently, the firm is deploying its technology to distinguish between a bacterial and viral infection within 10 minutes from a finger-prick sample, allowing doctors to personalise and speed up patient treatments. The startup, co-founded by #NTUsg Prof Peter Preiser and NTU alumna Dr Emma HUAN JIA with their partners from SMART (Singapore-MIT Alliance for Research & Technology Centre), received early-stage support from NTUitive through the Strategic Research Innovation Fund. Thrixen's CEO Shavit N. Clein said the new investment from this round will help to accelerate access to the US market and bring in experience, with 22Health Ventures founder and managing partner Ara Tavitian joining Thrixen's board. https://lnkd.in/g23wBkTT #NTUsgInnovation #NTUsg2025 #Healthtech #Innovation #Diagnostics #Startups #Funding NTU Innovation and Entrepreneurship (NTU I&E) #NTUsgAlumni National Research Foundation Singapore

We are happy to share that we have launched our inaugural SG-U.S. Market Access Program! This program is specifically designed to help Singapore MedTech Companies to boost internal capabilities and open up vast opportunities in the U.S. Market. Our SG-U.S. Market Access Cohort Companies will join us for our Annual MedTech Innovator Summit in San Francisco! We are excited to introduce these 10 companies in this program: Aevice Health, Breathonix Pte Ltd, Castomize, CoNEX Healthcare, Credo Diagnostics Biomedical, FathomX, NDR Medical Technology Pte Ltd, Neurowyzr, StratifiCare™ Pte. Ltd. and Thrixen! The agenda will be packed with pitch presentations, investor meetings, coaching and networking with partners! Stay tuned! Fredrik Nyberg Glen Lim #mtiapac #USMarketAccess #InnovatorSummit This program is supported by Enterprise Singapore.

I am thrilled to announce that Thrixen has secured new investors who share our vision for the future of diagnostics! We are honored that they have put their trust in our team and technology. We have been working closly with the amazing team at 22Health Ventures who are true partners in our journey to improve healthcare outcomes for patients all over the world. And we are very excited about what the next stage of our journey holds. Together with John Ballantyne who's support and guidance has been invaluable, we have an incredible team to help us achieve our vision for Thrixen. Stay tuned for more updates on our exciting journey ahead. #futureofdiagnostics #investment #pointofcare #thrixen Patthara Kongsuphol, HUAN JIA, Peter Preiser, Hadley Sikes, Megan McBee, Paul Scibetta, Jonathan Bandel, Louise Roman, Chern Chet Yong, Zsolt Kulcsar DO, MPH, MBA,

I am thrilled to announce that Thrixen has secured new investors who share our vision for the future of diagnostics! We are honored that they have put their trust in our team and technology. We have been working closly with the amazing team at 22Health Ventures who are true partners in our journey to improve healthcare outcomes for patients all over the world. And we are very excited about what the next stage of our journey holds. Together with John Ballantyne who's support and guidance has been invaluable, we have an incredible team to help us achieve our vision for Thrixen. Stay tuned for more updates on our exciting journey ahead. #futureofdiagnostics #investment #pointofcare #thrixen Patthara Kongsuphol, HUAN JIA, Peter Preiser, Hadley Sikes, Megan McBee, Paul Scibetta, Jonathan Bandel, Louise Roman, Chern Chet Yong, Zsolt Kulcsar DO, MPH, MBA,